Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Interim Results

26th Oct 2011 07:00

RNS Number : 8372Q
Lombard Risk Management PLC
26 October 2011
 



26 October 2011

 

Lombard Risk Management plc Interim results for the six months ended 30 September 2011

Lombard Risk maintains growth momentum

LONDON, UK - 26 October 2011: Lombard Risk Management plc (LSE:LRM) ("Lombard Risk" or "The Company"), a leading global provider of collateral management, liquidity and regulatory reporting and compliance solutions for the financial services industry, is pleased to announce its interim results for the six months ended 30 September 2011.

 

• Highlights

• Revenue up 10% on same period last year at £6.4m (2010: £5.8m).

• Significant increase in profit before tax to £1.8m (2010: £0.2m).

• Cash at end of period £1.3m (2010: £1.3m) with no debt (2010: £nil).

• Profitability achieved by both the Regulatory and the Trading and Risk businesses with a particularly strong advance by the Risk business.

• Contract for global application of COLLINE® at Société Générale.

• Launched latest web-enabled version of regulatory product.

• Maiden dividend of 0.03 pence per ordinary share of 0.5p ("Ordinary Share") paid; interim dividend of 0.02 pence per Ordinary Share approved by the Board in respect of the half year to 30 September 2011 and to be paid on 9 November to shareholders on the register as at 7 November 2011.

 

Current trading and outlook

Ongoing demand for COLLINE®: COLLINE® Collateral Management and Clearing software is now the product of choice for two Tier 1 banks with interest shown by a wide range of other banks and financial organisations.

Regulatory requirements imposed on financial organisations continue to expand: Significant additional regulatory reform such as Basel III, the Dodd-Frank Act and Solvency 2 should benefit the Company appreciably over the next few years.

Strong balance sheet: The combination of £1.3m cash position, no debt and good recurring revenues is a solid platform for future organic growth.

 

Report of Philip Crawford, Non-executive Chairman

The rise in profitability in the period is a good outcome, with a particularly strong performance by the collateral and clearing business. The Board continues to see considerable opportunities over the next few years from the areas in which the Company is operating, with the move to clearing of derivatives opening up new revenue streams. In addition, multiple regulatory initiatives, together with a complete refresh of our regulatory technology, offer us significant growth potential. The clear goal is that Lombard Risk will over the next few years be operating in growing markets and at the same time win an increasing market share of those markets.

 

Philip Crawford

Chairman

Report of John Wisbey, Chief Executive Officer

Summary

 

I am pleased to report a 10% rise in revenues and a significant rise in profitability for the six month period, as well as a net cash position of over £1.3m at the end of the period. The collateral management business performed particularly well. The rise in revenue was despite the fact that this financial year is a year of comparatively little regulatory change in the UK.

 

In the collateral and clearing software business, we continued to win contracts for our COLLINE® software both from existing and new customers. Some of the initiatives in this field, such as the move towards central clearing of derivatives and the integration by more banks of their collateral business with their repo and securities lending business, are proving beneficial to the Company. We signed two major deals for our COLLINE® software in the period, one with Société Générale and the other for clearing with the same major Tier 1 German bank with which we announced a contract in April 2009. These contracts together are worth £3.0 million in revenue to the Company in the first two years. We won several other contracts in the period including a large Austrian bank and a life insurance company in the United States, both for COLLINE®, a major European bank for Chinese regulatory reporting and a major US bank for Irish regulatory reporting.

 

In July the Board was required to make a public statement following an article in a London newspaper that a competitor had approached the Company with an offer valuing it at £40.0m or 20p per share. In the event, while no offer was formally made, it did highlight the fact that at that time the Company's shares were valued at well below 2 x revenues, whereas M&A activity in our sector has taken place at above 4 x revenues.

 

The Board considers that the Company's products are well placed in the current and foreseeable market with an emphasis on collateral and clearing, liquidity and regulatory compliance and related management reporting. The sales pipeline is strong and we have continued to win large deals in Europe despite the troubles of Greece and the Eurozone and the possible need for a number of our customers to raise additional capital to accommodate asset write downs.

 

Financial

 

Revenues for the six month period ended 30 September 2011 increased by 10% to £6.4m (2010: £5.8m). Profit before tax was sharply higher at £1.8m (2010: £0.2m). In the period the Company capitalised £1.3m of development costs (2010: £nil) with associated amortisation of £0.1m (2010: £nil). This is consistent with the Company's accounting policy and in line with the expectation set out in the Company's latest annual report. The total expenditure on software research and development in the period was £1.8m. The capitalised development costs are being amortised over a five year period. This is a change in our accounting policy that previously stated a three year amortisation period. There is no effect on prior year numbers.

 

It is pleasing that profit before software capitalisation nearly quadrupled against the same period last year and that in the first half of the financial year we have almost achieved the market's profit before tax expectations for the full financial year to 31 March 2012.

 

Net cash was £1.3m, a similar level to last year.

 

Recurring revenues, such as annual licence renewals and support and maintenance fees, have continued to grow. Such revenues have totalled £2.6m for the six month period. In addition, many customers are on term licences in excess of one year (typically three or five years) which are periodically renewed. These revenues significantly increase the percentage of the Company's revenues that may be classified as recurring.

 

Collateral and Clearing Software Products

 

COLLINE®, our collateral management and clearing software product, has performed very well. This product now handles substantially all of the key requirements of a collateral and clearing business including margining, repo and securities lending, trade reconciliation, inventory management and reporting including regulatory reporting (e.g. for Fed-15 reports and outputs to regulatory liquidity reporting). We extended our COLLINE® contract with a Tier 1 German bank to include Clearing, a contract worth £1.0 million in revenue to the Company over its first two years, and we expect a number of contracts with existing and prospective customers to follow. Another Tier 1 bank, Société Générale, became a customer in the summer, a contract worth more than £2.0 million in revenue to the Company in the first two years. We also signed up Erste Bank, a major Austrian bank, and PGA, a subsidiary of Pacific Life.

 

Volumes in the market have risen appreciably during the Eurozone crisis and COLLINE® has coped with increased volumes extremely well. A key element of our product is that it remains scalable from the smallest collateral user to the largest global bank using us for all its collateral and clearing.

 

OBERON®, our most established product, continues to move forward with functional and performance enhancements and remains profitable. With the recent financial crisis, money market rates for Swiss Francs and Singapore Dollars turned negative for a while and we ensured that our option models coped.

 

Our LISA® product, launched last year, continues to make progress as we move it towards a liquidity risk solution as well as a product for stress testing regulatory reports. LISA® was part of our solution for several of the more than thirty clients that used us for the FSA's liquidity reporting.

 

Regulatory and Compliance Software Products

 

Lombard Risk's Reporter product remains the market leader of any single solution for UK bank regulatory reporting with approximately 130 of the 350 banks in the UK and approximately fifteen investment firms in the UK using the product for regulatory reporting to the FSA.

 

Last year, the UK made the most significant contribution to this division, but this year we are in between the Liquidity Rules of 2010 and the COREP and Basel 3 and Solvency 2 Rules of 2012 onwards. With no major UK regulatory change this year, we made a concerted effort to increase our focus on foreign markets. We obtained a major US bank client for Irish reporting, while a European bank extended its existing use of Reporter in several Asian countries including China. With regulatory change also imminent in India in 2012 we are busy producing an Indian solution that meets the new rules and identifying likely initial clients.

 

Our technology team has been working hard on the transition to a web-based version of our Reporter product. In producing the resultant Version 5, we listened carefully to our 250+ large and small clients alike in various countries and to other firms that were looking for a robust, multi-country reporting solution architecture to cope with all the regulatory change that is occurring. This enhanced, web-based version is driven by our own vision of modern regulatory reporting and aims to address the major business issues raised by the many firms to whom we have talked. The initial client feedback to Version 5 has been positive both from existing customers and prospective ones and, as a result, the Board expects Version 5 to make a positive contribution to future revenue of the Company. Our aim is simple but ambitious - to make our product attractive to all serious firms that are looking at regulatory reporting, whether in one country or across multiple jurisdictions.

 

Personnel and Premises

 

We have continued to make several new hires appropriate to the expected growth of parts of the business but we continue to focus resources on those parts of the business where we see the best prospects. With 120 people now in our Shanghai development centre and over 200 employees overall, there has also been an appreciable focus on making processes more efficient.

 

We have moved to new premises in New York.

 

Prospects

 

The Group has seen some significant contract wins in the first half of the current financial year and has a strong pipeline of new business going into the second half. The Board sees no end in sight to the increase in bank and securities firm regulation at a national, supranational and international level. We are optimistic that this will have a positive effect on the Group's regulatory compliance business, albeit that this benefit will fluctuate as demand is driven by regulatory deadlines. The climate for the next few years is for mandatory additional spend on regulation.

 

However strong our pipeline, it is clearly a matter of concern for any company in any sector when the Bank of England Governor speaks of the current financial crisis as being the worst since the 1930s or possibly ever. We are fully aware of the current economic environment and it cannot be ruled out that our bank customers or prospective customers will reduce or delay their spending programmes, even though we have not seen this have a significant effect on our business thus far. We take comfort from the fact that regulatory spending is mostly mandatory and that collateral is one of the more important areas for many banks' spending at present.

 

The Board views the next two years with cautious optimism despite the difficult backdrop of the sovereign debt crisis in Europe and the impact that sovereign debt provisioning will have on the need to recapitalise the banking sector. The expectation remains that Lombard Risk's chosen markets of collateral and clearing, liquidity and regulatory compliance and related management reportingwill continue to be growing markets over the next few years and that at the same time we will win an increasing share of those markets.

 

Finally, we are pleased to announce that the Directors are recommending an interim dividend of 0.02 pence per Ordinary Share in respect of the half year to 30 September 2011. The interim dividend is payable on 9 November to shareholders on the register as at 7 November 2011.

 

 

John Wisbey

Chief Executive Officer

 

Consolidated unaudited interim statement of comprehensive income

For the six months ended 30 September 2011

 

Unaudited

Unaudited

Audited

Six months ended

Six months ended

Year ended

30 September 2011

30 September 2010

31 March 2011

Note

£000

£000

£000

Continuing operations

Revenue

6,352

5,800

11,801

Cost of sales

(44)

(48)

(82)

Gross profit

6,308

5,752

11,719

Administrative expenses

(4,556)

(5,602)

(11,159)

Profit from operations

1,752

150

560

Net finance income

1

4

5

Profit before taxation

1,753

154

565

Taxation (charge)/credit

3

(1)

(3)

708

Profit for the period transferred to reserves

1,752

151

1,273

Other comprehensive income

Exchange differences on translating foreign operations

4

(3)

(21)

Total comprehensive income for the period

1,756

148

1,252

Earnings per share

Basic (pence)

2

0.85

0.07

0.62

Diluted (pence)

2

0.78

0.07

0.62

 

Consolidated unaudited interim statement of financial position

As at 30 September 2011

Unaudited

Unaudited

Audited

As at

As at

As at

30 September 2011

30 September 2010

31 March 2011

£000

£000

£000

Non-current assets

Property, plant and equipment

139

108

104

Goodwill

3,633

3,633

3,633

Other intangible assets

1,267

7

11

Deferred tax asset

721

-

721

5,760

3,748

4,469

Current assets

Trade and other receivables

2,916

1,331

1,253

Cash and cash equivalents

1,346

1,306

1,782

4,262

2,637

3,035

Total assets

10,022

6,385

7,504

Current liabilities

Trade and other payables

(2,183)

(1,974)

(1,978)

Deferred income

(3,552)

(2,921)

(2,950)

Total liabilities

(5,735)

(4,895)

(4,928)

Net assets

4,287

1,490

2,576

Equity

Share capital

1,464

1,464

1,464

Share premium account

4,795

4,795

4,795

Foreign exchange reserves

(80)

(67)

(84)

Other reserves

1,681

1,683

1,664

Retained deficit

(3,573)

(6,385)

(5,263)

Total equity

4,287

1,490

2,576

 

 

Consolidated unaudited interim statement of changes in equity

For the six months ended 30 September 2011

Share

Foreign

Share

premium

exchange

Other

Profit and

Total

capital

account

reserves

reserves

loss account

equity

£000

£000

£000

£000

£000

£000

Balance at 1 April 2010

1,464

4,795

(64)

1,669

(6,536)

1,328

Share-based payment charge

-

-

-

14

-

14

Transaction with owners directly in equity

-

-

-

14

-

14

Profit for the period

-

-

-

-

151

151

Other comprehensive income

Exchange differences on translating foreign operations

-

-

(3)

-

-

(3)

Total comprehensive income for the period

-

-

(3)

-

151

148

Balance at 30 September 2010

1,464

4,795

(67)

1,683

(6,385)

1,490

 

Share

Foreign

Share

premium

exchange

Other

Profit and

Total

capital

account

reserves

reserves

loss account

equity

£000

£000

£000

£000

£000

£000

Balance at 1 October 2010

1,464

4,795

(67)

1,683

(6,385)

1,490

Share-based payment charge

-

-

-

(19)

-

(19)

Transaction with owners directly in equity

-

-

-

(19)

-

(19)

Profit for the period

-

-

-

-

1,122

1,122

Other comprehensive income

Exchange differences on translating foreign operations

-

-

(17)

-

-

(17)

Total comprehensive income for the period

-

-

(17)

-

1,122

1,105

Balance at 31 March 2011

1,464

4,795

(84)

1,664

(5,263)

2,576

 

Share

Foreign

Share

premium

exchange

Other

Profit and

Total

capital

account

reserves

reserves

loss account

equity

£000

£000

£000

£000

£000

£000

Balance at 1 April 2011

1,464

4,795

(84)

1,664

(5,263)

2,576

Share-based payment charge

-

-

-

17

-

17

Dividends

-

-

-

-

 (62)

(62)

Transaction with owners directly in equity

-

-

-

17

(62)

45

Profit for the period

-

-

-

-

1,752

1,752

Other comprehensive income

Exchange differences on translating foreign operations

-

-

4

-

-

4

Total comprehensive income for the period

-

-

4

-

1,752

1,756

Balance at 30 September 2011

1,464

4,795

(80)

1,681

(3,573)

4,287

 

 

Consolidated unaudited interim statement of cash flow

For the six months ended 30 September 2011

Unaudited

Unaudited

Audited

Six months ended

Six months ended

Year ended

30 September 2011

30 September 2010

31 March 2011

£000

£000

£000

Cash flows from operating activities

Profit for the period

1,752

151

1,273

Tax charge/(credit)

1

3

(708)

Net finance income

(1)

(4)

(5)

Operating profit

1,752

150

560

Adjustments for:

Depreciation

60

61

124

Amortisation

82

6

13

Share-based payment charge

17

14

(5)

(Increase)/decrease in trade and other receivables

 (1,663)

248

327

Increase in trade and other payables

205

20

7

Increase in deferred income

602

127

156

Foreign exchange difference

4

(10)

-

Cash generated by operations

1,059

616

1,182

Tax paid

(1)

(3)

(13)

Net cash generated by operating activities

1,058

613

1,169

Cash flows from investing activities

Interest received

1

4

1

Purchase of property, plant and equipment

(95)

(11)

(76)

Purchase of intangible fixed assets

(51)

(3)

(14)

Capitalisation of development expenditure

(1,287)

-

-

Net cash used in investing activities

(1,432)

(10)

(89)

Cash flows from financing activities

Dividends paid

(62)

-

-

Net cash flow used in financing activities

(62)

-

-

Net (decrease)/increase in cash and cash equivalents

(436)

603

1,080

Cash and cash equivalents at beginning of period

1,782

702

702

Cash and cash equivalents at end of period

1,346

1,305

1,782

 

 

Notes to the interim report

For the six months ended 30 September 2011

 

1. Basis of preparation

This interim report was approved by the Board on 25 October 2011.

 

These consolidated financial statements are for the six months ended 30 September 2011. They have been prepared in accordance with International Financial Reporting Standards ("IFRS") and International Financial Reporting Interpretation Committee ("IFRIC") interpretations as at 30 September 2011, as adopted by the European Union. They do not include any of the information required for full annual financial statements and should be read in conjunction with the consolidated financial statements of the Group for the year ended 31 March 2011.

 

The preparation of financial statements under IFRS requires the Board to make judgements, estimates and assumptions that affect the application of accounting policies, the reported amounts of statement of financial position items at the period end and the reported amount of revenue and expense during the reporting period. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making judgements that are not readily apparent from other sources. However, the actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis.

 

This condensed consolidated financial information does not comprise statutory accounts within the meaning of Section 434 of the Company Act 2006. Statutory accounts for the year ended 31 March 2011 were approved on 27 May 2011. These accounts, which contain an unqualified audit report under Section 495 of the Companies Act 2006 and which did not make any statements under Section 498 of the Companies Act 2006, have been delivered to the registrar of companies in accordance with Section 441 of the Companies Act 2006.

 

2. Earnings per share

Basic earnings per share has been calculated by dividing the profit on ordinary activities after taxation by the weighted average number of ordinary shares in issue during each period.

 

Diluted earnings per share is calculated by adjusting the weighted average number of ordinary shares in issue on the assumption of conversion of all dilutive potential ordinary shares. The Group has only one category of dilutive potential ordinary shares, share options granted under the Enterprise Management Incentive Plan and Unapproved Scheme.

 

Unaudited

Unaudited

Audited

Six months ended

Six months ended

Year ended

30 September 2011

30 September 2010

31 March 2011

£000

£000

£000

Profit for the period and basic and diluted earnings attributable to ordinary shareholders

1,752

151

1,273

Weighted average number of ordinary shares

206,926,786

206,926,786

206,926,786

Earnings per share (pence)

0.85

0.07

0.62

Effect of dilutive share options

Adjusted weighted average number of ordinary shares

225,336,786

206,926,786

206,926,786

Diluted earnings per share (pence)

0.78

0.07

0.62

There is no dilutive effect of share options in the year ended 31 March 2011 as the average price of the Company's shares was below the strike price of the options in issue.

 

3. Taxation

No material taxation charge is expected for the full year. This is as a result of prior years' losses available within the Group.

  

Contacts

Lombard Risk Management plc
Tel: 020 7593 6700
www.lombardrisk.com
 
Philip Crawford, Chairman
John Wisbey, CEO
Paul Tuson, CFO
Allenby Capital Limited
Tel: 020 3328 5656

Brian Stockbridge / Alex Price

 

Threadneedle Communications
Tel: 020 7653 9850
Graham Herring/Terry Garrett
 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR QELFLFBFEFBB

Related Shares:

Lombard Risk Management
FTSE 100 Latest
Value8,275.66
Change0.00